Nerve stimulation helps with overactive bladder

May 30, 2013
Nerve stimulation helps with overactive bladder
Electric impulses from a hand-held device travel from the nerves in the ankle to the nerves that control pelvic floor function.

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms.

Tibial is a painless procedure that takes place in an outpatient setting. A slim needle is inserted in the ankle, near the tibial nerve. It carries electric impulses from a hand-held stimulator to the nerves in the spinal cord that control function.

Principal investigator Kenneth Peters, M.D., chief of Urology at Beaumont Hospital, Royal Oak and a team of researchers reviewed data of 29 patients who initially responded to 12 weekly neuromodulation system treatments for OAB. were followed for three years.

Participants received an average of one tibial nerve treatment per month. After 14 weeks of treatment, 77 percent of patients maintained "moderate or marked improvement" in OAB symptoms.

For those who participated in the study, results show frequent trips to the bathroom during the day decreased by nearly 30 percent, or from 12 to 8.7; nighttime trips decreased by almost 40 percent, or from 2.7 to 1.7; and urge incontinence episodes per day decreased by 100 percent.

"This study demonstrates that with ongoing therapy patients with can have fewer symptoms and can return to daily activity without disruption or embarrassment that is often caused by this condition," says Dr. Peters.

According to the Urology Care Foundation, about 33 million Americans – men and women – have OAB. The number of people diagnosed with OAB may be much larger because many people living with this condition don't ask for help; they are embarrassed or unaware of available treatments.

Explore further: Unmet expectations and smoking prove key factors in quitting bladder medication

More information: www.jurology.com/article/S0022-5347(12)05807-7/abstract

Related Stories

Recommended for you

New drug to fight fatal but neglected tropical disease

August 31, 2016

In a breakthrough for those infected by the parasites that cause sleeping sickness, a young Queensland researcher has identified a compound that kills the parasites in the lab without having any toxic effect on human cells.

Traces of Ebola virus linger longer than expected in semen

August 31, 2016

Initial data from a Liberian public health program show about 9 percent (38) of 429 male Ebola survivors had fragments of Ebola virus in their semen. Of those, 63 percent had semen samples that tested positive for Ebola fragments ...

Researchers discover a drug for a tropical disease

August 30, 2016

Researchers at the University of Georgia are working to find the fastest way possible to treat and cure human African trypanosomiasis, long referred to as sleeping sickness. By working to improve chemical entities already ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.